AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2018
Sep 13, 2018
30786_dirs_2018-09-13_23a7c33d-b994-411d-9484-37ee0c6e345c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-09-11
Reporting Person: Crowley Michael (EVP, GBL Commercial Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-09-11 | Bio-Rad A Common Stock | M | 976 | — | Acquired | 4156 | Direct |
| 2018-09-11 | Bio-Rad A Common Stock | F | 339 | $308.37 | Disposed | 3817 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-09-11 | Restricted Stock Units | $0 | M | 376 | Disposed | Bio-Rad A Common Stock (376) | Direct | |
| 2018-09-11 | Restricted Stock Units | $0 | M | 600 | Disposed | Bio-Rad A Common Stock (600) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest in five equal annual installments beginning September 11, 2014.
F4: The restricted stock units vest in five equal annual installments beginning September 11, 2016.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13